Liabilities and Equity of Can-Fite BioPharma Ltd. from 31 Dec 2018 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Can-Fite BioPharma Ltd. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2018 to 30 Jun 2025.
  • Can-Fite BioPharma Ltd. Liabilities and Equity for the quarter ending 30 Jun 2025 was $7,720,000, a 30% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $7,720,000 +$1,798,000 +30% 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q4 2024 $9,120,000 -$869,000 -8.7% 31 Dec 2024 6-K 28 Aug 2025 2025 Q2
Q2 2024 $5,922,000 -$5,110,000 -46% 30 Jun 2024 6-K 29 Aug 2024 2024 Q2
Q4 2023 $9,989,000 +$706,000 +7.6% 31 Dec 2023 20-F 14 Apr 2025 2024 FY
Q2 2023 $11,032,000 -$3,714,000 -25% 30 Jun 2023 6-K 31 Aug 2023 2023 Q2
Q4 2022 $9,283,000 -$10,970,000 -54% 31 Dec 2022 20-F 28 Mar 2024 2023 FY
Q2 2022 $14,746,000 +$5,066,000 +52% 30 Jun 2022 6-K 25 Aug 2022 2022 Q2
Q4 2021 $20,253,000 +$10,730,000 +113% 31 Dec 2021 20-F 30 Mar 2023 2022 FY
Q2 2021 $9,680,000 -$3,120,000 -24% 30 Jun 2021 6-K 26 Aug 2021 2021 Q2
Q4 2020 $9,523,000 +$1,349,000 +17% 31 Dec 2020 20-F 24 Mar 2022 2021 FY
Q2 2020 $12,800,000 30 Jun 2020 6-K 27 Aug 2020 2020 Q2
Q4 2019 $8,174,000 +$222,000 +2.8% 31 Dec 2019 20-F 25 Mar 2021 2020 FY
Q4 2018 $7,952,000 31 Dec 2018 6-K 01 Jun 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.